Knopp News Archive
Knopp News
Knopp Biosciences to Present Clinical Data for Dexpramipexole at 11th Biennial Symposium of the International Eosinophil Society
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference
Knopp Biosciences to Present Data on its Potassium Channel Activator Program at 2019 Antiepileptic Drug and Device Trials XV Conference
Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome
Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic Asthma
CEO Dr. Michael Bozik’s interview with “The Heartbeat of Main Street” with Bank of America and ForbesBooks
Knopp Biosciences’ Rachel Kopper Elected National President of Women In Bio